Information Provided By:
Fly News Breaks for February 13, 2018
CME, CBOE
Feb 13, 2018 | 07:21 EDT
UBS analyst Alex Kramm lowered his price target on Cboe Global Markets (CBOE) to $120 from $136 as he sees limited room for multiple expansion and headline risk including regulatory concerns. The shares have sold off on investors concerns related to its VIX franchise and negative estimate revisions related to higher expenses and tax guidance. The analyst prefers CME (CME) as a play on higher volatility. However, Kramm maintained his buy rating on Cboe shares.
News For CBOE;CME From the Last 2 Days
There are no results for your query CBOE;CME